Insiders Repligen Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
166.1 ^USD	-0.26%		-3.00%	-7.60%

Apr. 08	RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating	MT
Mar. 20	Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Repligen Corporation Appoints Maggie A. Pax as Board of Directors	Mar. 19	CI
Repligen Insider Sold Shares Worth $681,348, According to a Recent SEC Filing	Mar. 13	MT
Repligen Insider Sold Shares Worth $3,298,632, According to a Recent SEC Filing	Mar. 12	MT
Repligen Insider Sold Shares Worth $866,204, According to a Recent SEC Filing	Feb. 27	MT
Repligen Insider Sold Shares Worth $557,328, According to a Recent SEC Filing	Nov. 13	MT
Repligen Corporation Appoints Olivier Loeillot as President and Chief Commercial Officer	23-10-02	CI
Repligen Corporation Appoints Jason K. Garland as Chief Financial Officer Effective September 25, 2023	23-09-12	CI
Repligen Appoints Jason K. Garland as Chief Financial Officer	23-09-12	MT
Insider Sell: Repligen	23-08-30	MT
Insider Sell: Repligen	23-02-17	MT
Repligen Appoints Martin D. Madaus to Board of Directors	23-02-09	CI
Insider Sell: Repligen	22-11-14	MT
Insider Sell: Repligen	22-08-17	MT
Insider Sell: Repligen	22-08-05	MT
Insider Sell: Repligen	22-08-04	MT
Insider Sell: Repligen	22-08-02	MT
Insider Sell: Repligen	22-07-22	MT
Insider Sell: Repligen	22-05-26	MT
Repligen Corporation Appoints Konstantin Konstantinov to Board of Directors	22-05-26	CI
Repligen Corporation Promotes James Bylund to the Chief Operating Officer and Principal Operating Officer	22-01-04	CI

No results for this search